HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G

This article was originally published in The Rose Sheet

Executive Summary

Wash & Go European hair care brand representing less than 1% of P&G's overall sales, may be divested, firm announces Nov. 8. Although "profitable and highly recognized," the line is no longer a focus of P&G's hair care business, firm says. CEO A.G. Lafley committed to divesting non-core brands when he took the helm July 1 (1"The Rose Sheet" June 12, p. 11). While soliciting bids for the brand, the firm will sell only if it receives an "acceptable" offer, and vows to redeploy Wash & Go employees

You may also be interested in...



P&G Beauty Head Lafley Named CEO, Pepper Reinstated As Chairman

Procter & Gamble CEO-elect A.G. Lafley will use his past experience in revitalizing P&G's hair care business to recharge the consolidated company and forge a more carefully paced strategic direction. Lafley succeeds Durk Jager, who will retire July 1.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008660

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel